-
公开(公告)号:US20150342878A1
公开(公告)日:2015-12-03
申请号:US14578598
申请日:2014-12-22
发明人: David A. Edwards , Robert S. Langer , Rita Vanbever , Jeffrey D. Mintzes , Jue Wang , Donghao Chen
CPC分类号: A61K9/0073 , A61K9/0075 , A61K9/16 , A61K9/1617 , A61K9/1623 , A61K9/1641 , A61K9/1647 , A61K9/1658 , A61K9/1694 , A61K31/135 , A61K31/137 , A61K31/566 , A61K38/28 , A61K38/38 , A61K47/12 , A61K47/183 , A61K47/24 , A61K47/6927
摘要: The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent. Release of the agent from the administered particles occurs in a sustained fashion.
摘要翻译: 本发明一般涉及将治疗性预防和诊断试剂肺部递送给患者,其中药剂以持续方式释放,以及适用于该方法的颗粒。 特别地,本发明涉及用于肺部递送治疗性,预防性或诊断性药物的方法,其包括对需要治疗,预防或诊断的患者的呼吸道施用有效量的包含治疗性,预防性或诊断性的颗粒 药剂或其任何组合与带电脂质相结合,其中带电脂质具有与药剂相关的与药剂相反的总净电荷。 药剂从给药颗粒中的释放以持续的方式发生。
-
公开(公告)号:US20150104515A1
公开(公告)日:2015-04-16
申请号:US14277977
申请日:2014-05-15
发明人: David A. Edwards , Robert S. Langer , Rita Vanbever , Jeffrey D. Mintzes , Jue Wang , Donghao Chen
IPC分类号: A61K9/00 , A61K47/24 , A61K31/137 , A61K47/18 , A61K31/566 , A61K38/28 , A61K47/12
CPC分类号: A61K9/0073 , A61K9/0075 , A61K9/16 , A61K9/1617 , A61K9/1623 , A61K9/1641 , A61K9/1647 , A61K9/1658 , A61K9/1694 , A61K31/135 , A61K31/137 , A61K31/566 , A61K38/28 , A61K38/38 , A61K47/12 , A61K47/183 , A61K47/24 , A61K47/6927
摘要: The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent. Release of the agent from the administered particles occurs in a sustained fashion.
-